“…Unphosphorylated FTY720, in contrast, limits tumor cell growth and survival in vitro and in vivo by activating PP2A and disrupting endocytic trafficking (Kim et al, 2016;Romero Rosales et al, 2011). Unlike FTY720, the conformationally constrained FTY720 analog SH-BC-893 (893) does not activate S1P receptors, even in its phosphorylated form (Chen et al, 2016;Kim et al, 2016;Perryman et al, 2016). However, FTY720 and 893 produce identical disruptions in intracellular trafficking, and their IC50 values are closely matched, suggesting that effects on trafficking, not S1P receptors, are responsible for the anti-cancer activity of FTY720 (Kim et al, 2016;Romero Rosales et al, 2011).…”